CPSH

CPS Technologies Corporation

50
Fundamentals51/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential47/ 100

CPSH trails on the overall score without a compensating advantage in the available component scores.

PLTR

Palantir Technologies Inc.

90
Fundamentals95/ 100
Valuation88/ 100
Upside potential84/ 100
Risk potential21/ 100

PLTR has the edge over CPSH overall, supported by stronger fundamentals and stronger valuation.

CPSH Fundamentals

MetricStatus
Stable
Stable
Weak
Strong

CPSH's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is weak.

PLTR Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.

CPSH PE Valuation

CPSH has no meaningful PE right now: it lost money over the past year.

PLTR PE Valuation

CHEAPFAIREXPENSIVE174x349x523x698x
CHEAPFAIREXPENSIVE174x349x523x698x
LevelPEPriceVs current
Forward75x$172—
Current120x$172—
Cheap165x$236+37%
Fair251x$359+109%
Expensive452x$646+277%

Historical ranges are pointers, not guarantees.

PLTR's PE is in its cheap range at 120x. If earnings grow as analysts expect, today's price would be 75x next year's earnings.

CPSH Forward outlook

There aren't enough analyst estimates for CPSH to show an outlook.

PLTR Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for PLTR, with profitability improving.

CPSH Risk to reward

ScenarioChangePrice
Upside+87%$7.68
Downside-47%$2.19

Calculated from the latest close: $4.10 on Nov 12.

CPSH trails PLTR on modeled risk to reward, with less potential upside and more potential downside.

PLTR Risk to reward

ScenarioChangePrice
Upside+112%$364.26
Downside-21%$136.16

Calculated from the latest close: $171.58 on Nov 12.

PLTR has a better modeled risk to reward balance than CPSH, with more potential upside and less potential downside.

CPSH Earnings Per Share

Q4 2023: $0.09Q1 2024: $0.05Q2 2024: $-0.06Q3 2024: $-0.14Q4 2024: $-0.22Q1 2025: $-0.20Q2 2025: $-0.12Q3 2025: $-0.04Q4 2025: $0.03Q1 2026: $0.00Q2 2026: $-0.01Q3 2026: $0.00
Q4 2023: $0.09Q1 2024: $0.05Q2 2024: $-0.06Q3 2024: $-0.14Q4 2024: $-0.22Q1 2025: $-0.20Q2 2025: $-0.12Q3 2025: $-0.04Q4 2025: $0.03Q1 2026: $0.00Q2 2026: $-0.01Q3 2026: $0.00
QuarterTTM EPSYoY
Q3 2026$0.00+$0.04
Q2 2026-$0.01+$0.11
Q1 2026$0.00+$0.20
Q4 2025$0.03+$0.25
Q3 2025-$0.04+$0.10
Q2 2025-$0.12-$0.06
Q1 2025-$0.20-500%
Q4 2024-$0.22-344%

CPSH is still losing money, but far less than before: $0.00 per share over the past year, against $0.22 at its worst in late 2024.

PLTR Earnings Per Share

Q4 2023: $0.09Q1 2024: $0.12Q2 2024: $0.17Q3 2024: $0.20Q4 2024: $0.19Q1 2025: $0.23Q2 2025: $0.30Q3 2025: $0.42Q4 2025: $0.63Q1 2026: $0.89Q2 2026: $1.17Q3 2026: $1.43Forward: $2.30
Q4 2023: $0.09Q1 2024: $0.12Q2 2024: $0.17Q3 2024: $0.20Q4 2024: $0.19Q1 2025: $0.23Q2 2025: $0.30Q3 2025: $0.42Q4 2025: $0.63Q1 2026: $0.89Q2 2026: $1.17Q3 2026: $1.43Forward: $2.30
QuarterTTM EPSYoY
Forward$2.30+61%
Q3 2026$1.43+240%
Q2 2026$1.17+290%
Q1 2026$0.89+287%
Q4 2025$0.63+232%
Q3 2025$0.42+110%
Q2 2025$0.30+76%
Q1 2025$0.23+92%
Q4 2024$0.19+111%

PLTR has the edge over CPSH on earnings, with more consistent year-over-year improvement.

CPSH Quarterly Revenue

Q4 2023: $7MQ1 2024: $6MQ2 2024: $5MQ3 2024: $4MQ4 2024: $6MQ1 2025: $8MQ2 2025: $8MQ3 2025: $9MQ4 2025: $8MQ1 2026: $7MQ2 2026: $8MQ3 2026: $9M
Q4 2023: $7MQ1 2024: $6MQ2 2024: $5MQ3 2024: $4MQ4 2024: $6MQ1 2025: $8MQ2 2025: $8MQ3 2025: $9MQ4 2025: $8MQ1 2026: $7MQ2 2026: $8MQ3 2026: $9M
QuarterRevenueYoY
Q3 2026$8.9M+1.1%
Q2 2026$8.3M+2.9%
Q1 2026$7M-6.4%
Q4 2025$8.2M+38%
Q3 2025$8.8M+107%
Q2 2025$8.1M+61%
Q1 2025$7.5M+27%
Q4 2024$5.9M-12%

CPSH's revenue is growing: $9M last quarter, up 1.1% from the same quarter a year ago.

PLTR Quarterly Revenue

Q4 2023: $608MQ1 2024: $634MQ2 2024: $678MQ3 2024: $726MQ4 2024: $828MQ1 2025: $884MQ2 2025: $1BQ3 2025: $1.2BQ4 2025: $1.4BQ1 2026: $1.6BQ2 2026: $1.9BQ3 2026: $2.3B
Q4 2023: $608MQ1 2024: $634MQ2 2024: $678MQ3 2024: $726MQ4 2024: $828MQ1 2025: $884MQ2 2025: $1BQ3 2025: $1.2BQ4 2025: $1.4BQ1 2026: $1.6BQ2 2026: $1.9BQ3 2026: $2.3B
QuarterRevenueYoY
Q3 2026$2.3B+96%
Q2 2026$1.9B+93%
Q1 2026$1.6B+85%
Q4 2025$1.4B+70%
Q3 2025$1.2B+63%
Q2 2025$1B+48%
Q1 2025$883.9M+39%
Q4 2024$827.5M+36%

PLTR has the edge over CPSH on sales, with more consistent year-over-year improvement.

CPSH Free Cash Flow

Q4 2023: $45,995Q1 2024: −$134,489Q2 2024: −$2MQ3 2024: −$1MQ4 2024: −$1MQ1 2025: −$1MQ2 2025: $476,408Q3 2025: $876,808Q4 2025: −$494,441Q1 2026: −$767,793Q2 2026: −$2MQ3 2026: −$310,181
Q4 2023: $45,995Q1 2024: −$134,489Q2 2024: −$2MQ3 2024: −$1MQ4 2024: −$1MQ1 2025: −$1MQ2 2025: $476,408Q3 2025: $876,808Q4 2025: −$494,441Q1 2026: −$767,793Q2 2026: −$2MQ3 2026: −$310,181
QuarterFree cash flowYoY
Q3 2026-$310.2K-135%
Q2 2026-$2.4M-601%
Q1 2026-$767.8K+$578K
Q4 2025-$494.4K+$974.6K
Q3 2025$876.8K+$2.1M
Q2 2025$476.4K+$2.1M
Q1 2025-$1.3M-$1.2M
Q4 2024-$1.5M-3294%

CPSH has burned cash in six of the last eight quarters: −$4M over the past year, against −$1M the year before.

PLTR Free Cash Flow

Q4 2023: $296MQ1 2024: $127MQ2 2024: $141MQ3 2024: $416MQ4 2024: $457MQ1 2025: $304MQ2 2025: $532MQ3 2025: $501MQ4 2025: $764MQ1 2026: $892MQ2 2026: $1.2BQ3 2026: $1.2B
Q4 2023: $296MQ1 2024: $127MQ2 2024: $141MQ3 2024: $416MQ4 2024: $457MQ1 2025: $304MQ2 2025: $532MQ3 2025: $501MQ4 2025: $764MQ1 2026: $892MQ2 2026: $1.2BQ3 2026: $1.2B
QuarterFree cash flowYoY
Q3 2026$1.2B+139%
Q2 2026$1.2B+126%
Q1 2026$891.8M+193%
Q4 2025$764M+67%
Q3 2025$500.9M+20%
Q2 2025$531.6M+276%
Q1 2025$304.1M+140%
Q4 2024$457.2M+54%

PLTR has the edge over CPSH on cash generation, producing positive trailing cash flow while its opponent burns cash.

CPSH Total Shares

Q4 2023: 15MQ1 2024: 15MQ2 2024: 15MQ3 2024: 15MQ4 2024: 15MQ1 2025: 15MQ2 2025: 15MQ3 2025: 15MQ4 2025: 15MQ1 2026: 18MQ2 2026: 19MQ3 2026: 20M
Q4 2023: 15MQ1 2024: 15MQ2 2024: 15MQ3 2024: 15MQ4 2024: 15MQ1 2025: 15MQ2 2025: 15MQ3 2025: 15MQ4 2025: 15MQ1 2026: 18MQ2 2026: 19MQ3 2026: 20M
PeriodChange %Net change
Quarterly+4.8%+903K shares
1 year+35%+5.1M shares
3 years+35%+5.1M shares
5 years+33%+4.9M shares
Available history+50%+6.6M shares

CPSH has 20M diluted shares, up 35% from a year ago.

PLTR Total Shares

Q4 2023: 2.3BQ1 2024: 2.4BQ2 2024: 2.4BQ3 2024: 2.5BQ4 2024: 2.5BQ1 2025: 2.6BQ2 2025: 2.6BQ3 2025: 2.6BQ4 2025: 2.6BQ1 2026: 2.6BQ2 2026: 2.6BQ3 2026: 2.6B
Q4 2023: 2.3BQ1 2024: 2.4BQ2 2024: 2.4BQ3 2024: 2.5BQ4 2024: 2.5BQ1 2025: 2.6BQ2 2025: 2.6BQ3 2025: 2.6BQ4 2025: 2.6BQ1 2026: 2.6BQ2 2026: 2.6BQ3 2026: 2.6B
PeriodChange %Net change
Quarterly+0.2%+5.2M shares
1 year+0.1%+2.9M shares
3 years+11%+248M shares
5 years+31%+610M shares
Available history+184%+1.7B shares

PLTR has the edge over CPSH on shareholder dilution, with a more favorable share count trend.

CPSH Net Leverage

Q4 2023: -4.0xQ1 2024: -7.1xQ4 2025: -4.3xQ1 2026: -15.1xQ3 2026: -36.2x
Q4 2023: -4.0xQ1 2024: -7.1xQ4 2025: -4.3xQ1 2026: -15.1xQ3 2026: -36.2x
QuarterNet LeverageStatus
Q3 2026-36.2xNet Cash
Q1 2026-15.1xNet Cash
Q4 2025-4.3xNet Cash
Q1 2024-7.1xNet Cash
Q4 2023-4.0xNet Cash
Q3 2023-3.7xNet Cash
Q2 2023-2.9xNet Cash
Q1 2023-2.6xNet Cash

CPSH has the edge over PLTR on leverage, with a lower net debt burden relative to earnings.

PLTR Net Leverage

Q4 2023: -5.4xQ1 2024: -2.3xQ2 2024: -1.6xQ3 2024: -1.9xQ4 2024: -6.1xQ1 2025: -2.3xQ2 2025: -1.6xQ3 2025: -1.9xQ4 2025: -1.0xQ1 2026: -1.1xQ2 2026: -0.8xQ3 2026: -1.1x
Q4 2023: -5.4xQ1 2024: -2.3xQ2 2024: -1.6xQ3 2024: -1.9xQ4 2024: -6.1xQ1 2025: -2.3xQ2 2025: -1.6xQ3 2025: -1.9xQ4 2025: -1.0xQ1 2026: -1.1xQ2 2026: -0.8xQ3 2026: -1.1x
QuarterNet LeverageStatus
Q3 2026-1.1xNet Cash
Q2 2026-0.8xNet Cash
Q1 2026-1.1xNet Cash
Q4 2025-1.0xNet Cash
Q3 2025-1.9xNet Cash
Q2 2025-1.6xNet Cash
Q1 2025-2.3xNet Cash
Q4 2024-6.1xNet Cash

PLTR has more cash than debt.

CPSH Weekly Momentum

MetricValueStatus
RSI48.8Neutral
Stochastic36.9Neutral

CPSH's weekly RSI is 49 (neutral) and its Stochastic is 37 (neutral).

PLTR Weekly Momentum

MetricValueStatus
RSI51.4Neutral
Stochastic47.4Neutral

PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).

CPSH PE vs Technology Sector

MetricCPSHSector medianRelative
PEN/A28x—

CPSH has no meaningful PE right now: it lost money over the past year.

PLTR PE vs Technology Sector

MetricPLTRSector medianRelative
PE120x28x331% above
PE %13837 pts below

PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.

CPSH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.7210% above
20 week MA$4.041.5% above
50 week MA$4.519.1% below
100 week MA$3.5216% above
200 week MA$2.8942% above

CPSH's trend is mixed: it's above four of its five weekly moving averages, and 42% above its 200-week average.

PLTR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$185.87.6% below
20 week MA$167.62.4% above
50 week MA$157.19.2% above
100 week MA$143.819% above
200 week MA$83.3106% above

PLTR's trend is up, with a small recent dip: it's below only its 8-week average, and 106% above its 200-week average.

CPSH Yearly ROI

YearStart priceEnd priceROI
2020$1.05$2.29+118%
2021$2.29$4.34+90%
2022$4.34$2.75-37%
2023$2.75$2.35-15%
2024$2.35$1.62-31%
2025$1.62$3.21+98%
2026 YTD$3.21$4.10+28%

CPSH has the edge over PLTR on returns for 2026, with the stronger performance.

PLTR Yearly ROI

YearStart priceEnd priceROI
2020$9.20$27.8+202%
2021$27.8$18.9-32%
2022$18.9$6.29-67%
2023$6.29$17.2+173%
2024$17.2$79.1+361%
2025$79.1$188.7+139%
2026 YTD$188.7$171.6-9.1%

PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.

Give your agent the market.

Get API key